Clinical Trials Browser

Cytokine Release Syndrome × Calcium Dobesilate × 90 days × Clear all

NCT05972135 2026-04-22

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Multiple Myeloma